People · Operator
Named in public records as an officer, director or promoter · active 2015–2026 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Spyryx Biosciences, Inc. | — | Biotechnology | Series B | $29.1M | $235.4M | 2015 |
| Eldec Pharmaceuticals, Inc. | — | Pharmaceuticals | Pre-Seed | $200K | $351K | 2026 |
Robert Tarran at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Tarran on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Taylor | 1 | 10 |
| Tim Shannon | 1 | 9 |
| Christy Shaffer | 1 | 6 |
| Brian Daniels | 1 | 5 |
| Roger Jeffs | 1 | 3 |
| Robert Schotzinger | 1 | 2 |
| Timm Crowder | 1 | 1 |
| Andrew Jordan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.